T-cell/histiocyte-rich B-cell lymphoma: Clinical presentation, management and prognostic factors: report on 61 patients and review of literature

References

• Greer J P, Macon W R, Lamar R E, Wolff S N, Stein R S, Flexner J M, et al. T-cell-rich large B-cell lymphomas: Diagnosis and response to therapy of 44 patients. J Clin Oncol 1995; 13: 1742–1750
   PubMed Web of Science ®Google Scholar
• Bouabdallah R, Mounier N, Guettier C, Molina T, Ribrag V, Thieblemont C, et al. T-cell/histiocyte-rich large B-cell lymphomas and classical diffuse large B-cell lymphomas have similar outcome after chemotherapy: a matched-control analysis. J Clin Oncol 2003; 21: 1271–1277
   PubMed Web of Science ®Google Scholar
• Sehn L H, Donaldson J, Chhanabhai M, Fitzgerald C, Gill K, Klasa R, et al. Introduction of combined CHOP plus Rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia. J Clin Oncol 2005; 23: 5027–5033
   PubMed Web of Science ®Google Scholar
• Ramsay A D, Smith W J, Isaacson P G. T-cell rich B-cell lymphoma. Am J Surg Pathol 1988; 12: 433–443
   PubMed Web of Science ®Google Scholar
• Ng C S, Chan J KC, Hui P K, Lau W H. Large B-cell lymphoma with a high content of reactive T cells. Hum Pathol 1989; 20: 1145–1154
   PubMed Web of Science ®Google Scholar
• Osborne B M, Butler J J, Pugh W C. The value of immunophenotyping on paraffin sections in the identification of T-cell-rich B-cell large cell lymphomas: lineage confirmed by JH rearrangement. Am J Surg Pathol 1990; 14: 933–938
   PubMed Web of Science ®Google Scholar
• Chittal S M, Brousset P, Voigt J J, Delsol G. Large B-cell lymphoma rich in T-cells and simulating Hodgkin's disease. Histopathology 1991; 19: 211–220
   PubMed Web of Science ®Google Scholar
• Macon W R, Williams M E, Greer J P, Stein R S, Collins R D, Cousar J B. T-cell rich B-cell lymphomas: a clinicopathologic study of 19 cases. Am J Surg Pathol 1992; 16: 351–363
   PubMed Web of Science ®Google Scholar
• Delabie J, Vandenberghe E, Kennes C, Verhoef G, Foschini M P, Stul M, et al. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease. paragranuloma subtype. Am J Surg Pathol 1992; 16: 37–48
   PubMed Web of Science ®Google Scholar
• Lim M, Beaty M, Sorbara L, Cheng R Z, Pittaluga S, Raffeld M, et al. T-cell/histiocyte-rich large B-cell lymphoma. A heterogeneous entity with derivation from germinal B cells. Am J Surg Pathol 2002; 26: 1458–1466
   PubMed Web of Science ®Google Scholar
• Boudova L, Torlakovic E, Delabie J, Reimer P, Pfistner B, Wiedenmann S, et al. Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte predominant Hodgkin lymphoma and T cell/histiocyte-rich B cell lymphoma. Blood 2003; 102: 3753–3758
   PubMed Web of Science ®Google Scholar
• Baddoura F K, Chan W C, Masih A S, Mitchell D, Sun N C, Weisenburger D D. T-cell-rich large B-cell lymphoma. A clinicopathologic study of eight cases. Am J Clin Pathol 1995; 103: 65–75
   PubMed Web of Science ®Google Scholar
• Schmidt U, Metz K A, Leder L D. T-cell-rich large B-cell lymphoma and lympocyte predominant Hodgkin's disease: two closely related entities. Br J Haematol 1995; 90: 398–403
   PubMed Web of Science ®Google Scholar
• Rudiger T, Ott G, Ott M M, Müller-Deubert S M, Müller-Hermelink H K. Differential diagnosis between classic Hodgkin disease, T-cell rich B-cell lymphoma and paragranuloma by paraffin immunohistochemistry. Am J Surg Pathol 1998; 22: 1184–1191
   PubMed Web of Science ®Google Scholar
• Rodriguez J, Pugh W C, Cabnillas F. T-cell-rich B cell Lymphoma. Blood 1993; 82: 1586–1589
   PubMed Web of Science ®Google Scholar
• Krishnan J, Wallberg K, Frizzera G. T-cell-rich large B-cell lymphoma. A study of 30 cases supporting its histologic heterogeneity and lack of clinical distinctiveness. Am J Surg Pathol 1994; 18: 211–220
   PubMed Web of Science ®Google Scholar
• Achten R, Verhoef G, Vanuytsel L, De Wolf-Peeters C. T-cell/histocyte-rich large B-cell lymphoma: a distinct clinicopathologic entity. J Clin Oncol 2002; 20: 1269–1277
   PubMed Web of Science ®Google Scholar
• Ripp J A, Louie D C, Chan W, Nawaz H, Portlock C S. T-cell rich B-cell lymphoma: clinical distinctiveness and response to treatment in 45 patients. Leuk Lymphoma 2002; 43: 1573–1580
   PubMed Web of Science ®Google Scholar
• Aki H, Tuzuner N, Ongoren S, Baslar Z, Soysal T, Ferhanoglu B, et al. T-cell-rich B-cell lymphoma: a clinicopathologic study of 21 cases and comparison with 43 cases of diffuse large B-cell lymphoma. Leuk Res 2004; 28: 229–236
   PubMed Web of Science ®Google Scholar
• Abramson J S. T-cell/histiocyte-rich B-cell lymphoma: biology, diagnosis and management. The Oncologist 2006; 11: 384–392
   PubMed Web of Science ®Google Scholar
• Fraga M, Garcia-Riviero A, Sanchez-Verde L, García-Rivero A, Piris M A. T-cell/histiocyte-rich large B-cell lymphoma is a disseminated aggressive neoplasm: differential diagnosis from Hodgkin's lymphoma. Histopathol 2002; 41: 216–229
   PubMed Web of Science ®Google Scholar
• The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993; 329: 987–994
   PubMed Web of Science ®Google Scholar
• Gatter K C, Warnke R A. Diffuse large B cell lymphoma. Pathology and Genetics of Tumors of Hematopoietic and Lymphoid Tissues, E S Jaffe, N L Harris, J W Variman. IARC Press, Lyon 2001; 171–174
   Google Scholar
• Harris N L, Jaffe E S, Stein H, Banks P M, Chan J K, Cleary M L, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361–1392
   PubMed Web of Science ®Google Scholar
• Rudiger T, Jaffe E S, Delsol G, deWolf-Peeters C, Gascoyne R D, Georgii A, et al. Workshop on Hodgkin's disease and related disease (grey zone lymphoma). Ann Oncol 1998; 9(Suppl 5)31–38
   PubMed Web of Science ®Google Scholar
• Rudiger T, Gascoyne R D, Jaffe E S, de Jong D, Delabie J, De Wolf-Peeters C, et al. Workshop on the relationship between nodular lymphocyte predominant Hodgkin's lymphoma and T cell/histiocyte-rich B cell lymphoma. Ann Oncol 2002; 13: 44–51
   PubMed Web of Science ®Google Scholar
• McBride J A, Rodriguez J, Luthra R, Ordóñez N G, Cabanillas F, Pugh W C, et al. T-cell-rich B large cell lymphoma simulating lymphocyte-rich Hodgkin's disease. Am J Surg Pathol 1996; 20: 193–201
   PubMed Web of Science ®Google Scholar
• Armitage J O, Weisenburger D D. New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. J Clin Oncol 1998; 16: 2780–2795
   PubMed Web of Science ®Google Scholar
• Skinnider B F, Connors J M, Gascoyne R D. Bone marrow involvement in T-cell-rich B-cell lymphoma. Am J Clin Pathol 1997; 108: 489–491
   PubMed Web of Science ®Google Scholar
• Coiffier B. State-of-the-art therapeutics: diffuse large B-cell lymphoma. J Clin Oncol 2005; 23: 6387–6393
   PubMed Web of Science ®Google Scholar
• Pfreundschuh M, Trumper L, Osterborg A, Pettengell R, Trneny M, Imrie K, et al. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good prognosis diffuse large B-cell lymphoma: a randomized controlled trial by the MabThera International Trial (MinT) Group. Lancet Oncol 2006; 7: 379–391
   PubMed Web of Science ®Google Scholar